GNE-131 is primarily investigated for its potential in cancer therapy, particularly in targeting specific pathways involved in tumor growth and survival. It functions as a selective inhibitor of certain enzymes or proteins that play a critical role in cancer cell proliferation. Researchers are exploring its efficacy in preclinical studies to determine its ability to inhibit tumor progression and enhance the effectiveness of existing treatments. Its application is focused on developing targeted therapies for cancers where traditional treatments have limited success, offering a more precise approach to managing the disease.